A mouse study from Barcelona suggests Mounjaro does more than curb appetite — it may switch on a rare, calorie-torching fat tissue inside the body.
Picture two kinds of fat living inside you. One hoards energy like a miser. The other burns it like a furnace. Most people have heard of the first kind.
The second — brown adipose tissue — is the stranger, more exciting one. And a new study suggests that tirzepatide, the drug sold as Mounjaro, may know exactly how to turn it on. Scientists at the University of Barcelona, led by researcher Marion Peyrou of the Institute of Biomedicine (IBUB), ran a carefully controlled experiment on obese mice. The animals were fed a high-fat diet, then some received tirzepatide while others were given exactly the same amount of food but no drug.
That design was deliberate. It meant any difference observed between the two groups could not simply be blamed on eating less. The drug, it turned out, was doing something extra. What it was doing involved brown fat.